Sunday
04.21.2024
1:02 AM
Login form
Search
Calendar
Entries archive

My site

Main » 2022 » December » 13

JERSEY CITY, N.J. - Monday, 12. December 2022

Weaver officially takes on role after becoming interim head of the Office of General Counsel and Corporate Secretary in July 2022

(BUSINESS WIRE) -- Organon (NYSE: OGN), a global women’s healthcare company, today announced that Kirke Weaver has been appointed General Counsel and Corporate Secretary, and will continue as a member of Organon’s executive leadership team, effective January 1, 2023. Mr. Weaver was named as the interim head of the Office of General Counsel and Corporate Secretary in July 2022.

Mr. Weaver brings nearly 20 years of pharmaceutical industry experience to the role, successfully providing legal and business advice in the multi-faceted, changing healthcare environment. Prior to serving as interim General Counsel and Corporate Secretary, Mr. Weaver served as Senior Vice President, Commercial, Regulatory, Securities, Employment and Deputy Corporate Secretary at Organon. As a senior m ... Read more »

Views: 45 | Added by: africa-live | Date: 12.13.2022

Breakthrough Early Warning Solution, for Integration with Masimo Patient SafetyNet™, Is Designed to Help Clinicians Catch Deterioration in Patient Condition

(BUSINESS WIRE) -- Masimo (NASDAQ: MASI) today announced the limited market release of Sepsis Index (Si™), an early warning indicator designed to help clinicians identify possible sepsis in patients remotely monitored with Masimo Patient SafetyNet™. Patient SafetyNet, a powerful remote patient monitoring and surveillance system in use around the world, aggregates real-time physiological data from Masimo and third-party bedside monitoring equipment for display at central stations, allowing clinicians to monitor patient condition from afar. By continuously analyzing a variety of vital signs data and other clinical measurements together with EMR data captured by Patient SafetyNet, Si works by quantifying patient status in an easily interpretable sepsis risk score.

Sepsis Index, using the aggregated ... Read more »

Views: 54 | Added by: africa-live | Date: 12.13.2022 | Comments (0)

Dubai, United Arab Emirates - Monday, 12. December 2022 AETOSWire Print 


The entry into the region’s online market will be anchored on a high order customer experience and a product line up which exemplifies comfort and well-being

Ordering mattresses online - a trend which became popular at the height of the pandemic lockdown, is now here to stay, according to Sleepwell - a leading Asia-based mattress company, which launched today in GCC.

Sleepwell’s entry into the region comes against a backdrop of the region’s burgeoning eCommerce market, which is poised to grow from US$24 billion in 2020, to reach US$50 billion by 2025. This, according to analysts, will be driven by the region’s rising population, ballooning internet penetration and the disruptive buying patterns caused by the pandemic.

With five decades of experience in developing personalized sleeping solutions, Sleepwell’s portfolio includes three flagsh ... Read more »

Views: 41 | Added by: africa-live | Date: 12.13.2022 | Comments (0)

ESPOO, Finland - Monday, 12. December 2022 AETOSWire

(BUSINESS WIRE) -- On Saturday, 10th of December 2022 at 10:00 am EET, Tecnotree concluded the purchase of assets belonging to CognitiveScale(CS). The agreement covered the transfer of all CS Intellectual Property including its Truststar, Cortex, and Certfai platforms. Further, CognitiveScale Inc. has transferred all patents including 108 granted patents to Tecnotree. The award-winning AIML platform empowers businesses by automating decision intelligence while delivering trust and governance capabilities to detect and mitigate business risks. Today the platform provides highly personalized insights to more than 100 million customers in the United States across healthcare, commerce, insurance, realty, and fintech verticals. This transaction is aligned with Tecnotree’s current global strategy and customers’ expectations.

The integration of the award-winning CS cortex AI/ML engineering capabilities into Te ... Read more »

Views: 59 | Added by: africa-live | Date: 12.13.2022 | Comments (0)

HANGZHOU, China - Monday, 12. December 2022


(BUSINESS WIRE) -- With the advancement of technology to a new level, the application fields of security equipment have been widely expanded. Dahua Technology, a world-leading video-centric AIoT solution and service provider, actively supports the sustainable development of human and nature through its tech for good initiatives, and constantly brings positive impacts to the communities where it operates.

Advocating for a better world for every child and their families, Dahua proudly supports Starlight Children’s Foundation, an Australian nonprofit organization that offers vital services for ill and hospitalized children. Dahua has made both a direct donation and a program that allows the employees, customers and partners of the company to make donations which will be matched dollar for dollar by Dahua Australia.

Dahua also believes on the importance of educational and social institutions and how they ca ... Read more »

Views: 47 | Added by: africa-live | Date: 12.13.2022 | Comments (0)

− Company to Feature 15 Company-Sponsored and Nine Collaborative Abstracts in Oncology and Hematology
− Oral Presentations Include Updated Results from Phase 3 OPTIC Trial of ICLUSIG® (ponatinib) and First-In-Human Phase 1/2 Study of Modakafusp Alfa (TAK-573)

(BUSINESS WIRE) -- Takeda (TSE:4502/NYSE:TAK) today announced that it will present 15 company-sponsored abstracts at the 64th American Society of Hematology (ASH) Annual Meeting being held December 10-13, 2022 in New Orleans. Takeda’s latest research focuses on improving long-term outcomes for patients with hematologic diseases.

Takeda’s presentations will include oral sessions detailing a three-year update of the Phase 3 OPTIC trial demonstrating the efficacy and safety of ICLUSIG® (ponatinib) in patients with resistant chronic-phase chronic myeloid leukemia (CP-CML), and results from a first-in-human Phase 1/2 study evaluating modakafusp alfa (TAK-573) in patients with rel ... Read more »

Views: 45 | Added by: africa-live | Date: 12.13.2022 | Comments (0)